Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency

P. James, O. Salomon, D. Mikovic, F. Peyvandi

Research output: Contribution to journalArticlepeer-review

Abstract

Rare bleeding disorders (RBDs) are inherited deficiencies of coagulation factors such as fibrinogen, factor (F) II, FV, FVII, combined FV+FVIII, FX, FXI and FXIII. These disorders usually have a low prevalence in the general population and constitute approximately 3-5% of all coagulation disorders. However, in some countries they may have the same prevalence as haemophilia B due to the practice of consanguineous marriage. The clinical picture of RBDs is highly variable and can vary markedly from mild to severe, making both diagnosis and optimal treatment quite challenging. This review focuses on: (i) the efforts to establish a bleeding assessment tool adequate to RBDs, (ii) the optimal management of patients affected with FXI deficiency and (iii) the correlation between clinical severity and laboratory diagnosis when determining the minimum coagulant activity required to prevent bleeding in each RBD.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalHaemophilia
Volume20
Issue numberS4
DOIs
Publication statusPublished - 2014

Keywords

  • Bleeding assessment tools
  • Clinical severity
  • Factor XI treatment
  • Laboratory classification
  • Rare bleeding disorders

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency'. Together they form a unique fingerprint.

Cite this